Approved Study Database

Ref. No. Scientific Title Principal investigator
2025.497 Histone deacetylase 9 as a novel immunoregulator of therapy resistance in hepatocellular carcinoma. Prof. TONG Man
唐旻
2025.464 A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease Dr. TAN Guangming
譚廣明
2025.496 Predicting Chemotherapy Response in Advanced Pancreatic Ductal Adenocarcinoma Using Multimodal Artificial Intelligence Prof. XIA Xianfeng
2025.429 Viral infections and subsequent development of acute respiratory distress syndrome and interstitial lung disease Dr Ko Wai San Fanny
2025.437 Effects of a Mindfulness-based Caring program to reduce nurse stress, enhance job satisfaction and retention: A randomized controlled trial Ms. WONG Wing Yee
2025.442 Associations of poverty-related housing displacement and physical inactivity with adverse cardiovascular outcomes and healthcare utilisation: investigation on territory-wide household cohort Dr. CHAN Crystal Ying
2025.410 Analysis of tracking patients in secondary transportation in acute stroke patients: a survey and systematic review Dr. IP Bonaventure Yiu Ming
2025.414 DISON I Study (Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis - A First-In-Human Study) Prof. NG Chi Fai
2025.427 A Phase II trial on Fezolinetant for vasomotor symptoms in men receiving androgen deprivation therapy (ADT) for prostate cancer (Fez-Cap) Prof. NG Chi Fai
2025.419 A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease Prof. MA Ching Wan
馬青雲
2025.418 Effectiveness of a multi-component intervention (Physical Exercise, Cognitive Training, Social interaction) in reducing frailty among older adults in primary care: a pragmatic randomized controlled trial Prof. Wong Samuel Yeung-Shan
黃仰山
2025.433 A prospective observational study on the effect of TREM2 H157Y variant in Alzheimer’s disease Prof. KWOK Timothy
2025.441 Competing Risk Quantile Regression with Time-dependent Covariates Dr. SIT Tony
2025.426 ADdiction-Related Eye Assessment and Management (ADREAM) Dr. CHONG Kelvin Kam Lung
2025.440 The Influence of Pre-existing Achilles Tendinopathy Severity on Long-term Functional Outcomes After Achilles Tendon Repair Surgery Prof. LING Samuel Ka Kin
2025.408 Combined treatment for long COVID: cohort study Dr. CHONG Marc Ka Chun
2025.396 Effectiveness of a Multimodal Hybrid Onsite and Telecare Prehabilitation Program for Adolescent Idiopathic Scoliosis Patients Receiving Spinal Fusion Surgery: A Randomised Controlled Trial Dr. LAU Adam Yiu Chung
2025.407 Effect of an internet-based dialectical behaviour therapy-informed skills training for promoting smoking cessation of smokers: A pilot randomised controlled trial Prof. HO Long Kwan
2025.398 Quantifying Tremor Assessment using Data-Driven Algorithm Ms. SUEN Wing Sze
2025.406 Development and Validation of SMART (Simple Mild Cognitive Impairment Risk Test): A brief screening test for mild cognitive impairment Dr. LAM Bonnie Yin Ka
2025.397 The Dreamcatchers Programme – A Nurse-led Multicomponent Interventional Protocol to Improve Sleep Quality in Paediatric Oncology Patients: A Pilot Randomized Controlled Trial Miss Mak Shuk Yan
2025.405 Retrospective collection of TEE image with corresponding X-ray/CT/MR images and data, for Development Next-generation AI-XR Empowered Surgical Planning and Intraoperative Guidance System via Effective Fusion of Empirical Knowledge, Human Interaction, and Machine Inference. Prof. LEE Pui Wai
2025.386 A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012) Prof. MA Brigette Buig Yue
2025.385 A Phase 2 Study to Assess ADX-038 in Participants With Complement-Mediated Kidney Disease Prof. SZETO Cheuk Chun
司徒卓俊
2025.423 Examining the association between senior badminton athlete’s training routine, physical fitness, and injury incidence Dr. NG Johan
吳又言
2025.416 Prospective Multi-Centre Randomised Controlled Trial on the Effect of Collagen Scaffold Augmentation in Achilles Tendon Rupture Repair Dr. Ling Samuel
2025.417 Optimal acute adult psychiatric in-patient care in Hong Kong: a mixed-method study Ms. CHUNG Sui Mei
2025.431 Mental health trajectories and influencing factors among physical trauma patients in Hong Kong: a prospective longitudinal study Prof. HUNG Kevin Kei Ching
2025.378 Outcomes of patients with adrenocortical carcinoma in Hong Kong: a territory-wide study Dr. CHEUNG Kitty Kit Ting
2025.377 Outcomes of patients with adrenocortical carcinoma in Hong Kong: a territory-wide study Dr. TSANG Chiu Chi
2025.376 Outcomes of patients with adrenocortical carcinoma in Hong Kong: a territory-wide study Dr. WONG I Ming
2025.404 Oral microbiome as a non-invasive diagnostic for early detection of colorectal neoplasia Prof. YU Jun
2025.403 Integrated metabolomic and metagenomic biomarkers for early colorectal neoplasia diagnosis across diverse patient populations Prof. YU Jun
2025.392 PWH Spine Registry Dr. LAU Cyrus Tsun Kit
2025.382 A multicenter study on the clinicopathological and genetic features of myeloid neoplasms with isochromosome 17q Prof. NG Margaret Heung Ling
2025.402 Surgical accuracy of open platform image‐based robotic‐assisted total hip arthroplasty Prof. ONG Michael Tim Yun
2025.371 A Case-Control Study to Identify Risk Factors for Catheter fracture of Implanted Venous Access Port in the Oncology Department Ms. MAK So Shan
麥素珊
2025.393 Effects of dance-based multimodal exercise programme for managing chemotherapy-induced peripheral neuropathy in patients with colorectal cancer: A randomized controlled study Ms. LAU Ka Yan
2025.390 Perioperative haemostasis, Procedure-related Pain after Physiological or Pharmacological modifications of Local anaesthesia around the Eyes (P4LE) – a double-masked, split-face, active-controlled, pilot randomised clinical trial Dr. CHONG Kelvin Kam Lung
2025.389 Perioperative haemostasis, Procedure-related Pain after Physiological or Pharmacological modifications of Local anaesthesia around the Eyes (P4LE) – a double-masked, split-face, active-controlled, pilot randomised clinical trial Dr. WU Anson Chun Long
2025.401 Adapting the CORN Intraoperative-Acquired Pressure Injury Risk Assessment Scale to Operative Settings in Hong Kong Dr. CHAN Dorothy NS
2025.436 The Effects of artificial intelligence- based chatbot "NeuroBot" for improving anxiety of patients undergoing neurovascular surgeries: a randomised controlled trial Ms. HO Chung Man
2025.388 CCCG-ALL 2025 Intermediate- and high-risk B-cell acute lymphoblastic leukemia Prof. LI Chi Kong
Chi Kong LI
2025.400 Surgical accuracy of open platform image‐based robotic‐assisted total knee arthroplasty across different implants: a multicentre trial Prof. ONG Michael Tim Yun
2025.391 Using Radiation-free Ultrasound for Screening Scoliosis Among School Children in Hong Kong to Reduce Unnecessary X-ray Exposure Dr. KWAN Cheuk Kin
2025.372 A Randomized, Double-Blind, Active-Controlled Multicenter Phase 2 Study Evaluating the Efficacy and Safety of ALG-000184 Compared with Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg-Negative Adult Subjects with Chronic Hepatitis B Virus Infection (B-SUPREME) Prof. WONG Grace Lai Hung
2025.370 Understanding the disease burden and improving the long-term outcomes of childhood-onset nephrotic syndrome through big data analytics Prof. CHAN Yu Hin
2025.365 A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan in Combination with Pembrolizumab Versus Platinum-based Chemotherapy in Combination with Pembrolizumab, as First-line Therapy in Participants with Locally Advanced Unresectable or Metastatic HER2 overexpressing and PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer (DESTINY-Lung06) Dr. LOONG Herbert Ho Fung
2025.374 MUSCLE-ML: Multimodal integration of muscle strength, structure by Machine Learning for Precision Rehabilitation After ACL Injury Prof. YUNG Patrick Shu Hang
容樹恒
2025.367 Retention rate of adalimumab bio-original and biosimilars in rheumatic diseases: a real-world study from the Hong Kong Biologics Registry Dr. TANG Hoi San
鄧凱珊

Page 2 of 268.